Back to search

Article

Therapies for Long COVID in non-hospitalised individuals - from symptoms, patient-reported outcomes, and immunology to targeted therapies (The TLC Study): Study protocol

2021-12-21

Abstract excerpt

<h4>Introduction</h4> Individuals with COVID-19 frequently experience symptoms and impaired quality of life beyond 4-12 weeks, commonly referred to as Long COVID. Whether Long COVID is one or several distinct syndromes is unknown. Establishing the evidence base for appropriate therapies is needed. We aim to evaluate the symptom burden and underlying pathophysiology of Long COVID syndromes in non-hospitalised indiv...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
33cd045d-f52f-58a0-9eec-cc11d26d29ea
DOI
10.1101/2021.12.20.21268098
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Therapies for Long COVID in non-hospitalised individuals - from symptoms, patient-reported outcomes, and immunology to targeted therapies (The TLC Study): Study protocolDOI 10.1101/2021.12.20.21268098
Select a neighboring publication to make it the new centre.